Global WHO and public health WHO’s Technical Advisory Group on COVID-19 Vaccine Composition (TAG‑CO‑VAC) is preparing its next decision on updated COVID‑19 vaccine antigen composition, with a meeting scheduled for May 2026; manufacturers are being asked to submit current epidemiologic, immunologic, and virologic data to inform strain‑selection decisions for future formulations. WHO continues to frame COVID‑19 vaccine updates around the genetic and antigenic evolution of circulating variants and the kinetics of waning protection, emphasizing the lead time needed for manufacturers to update authorized products. World Immunization Week 2026 (24–30 April) will again promote routine immunization across the life course, reiterating the estimate that vaccines have averted more than 150 million deaths over the past 50 years. South‑East Asia Indonesia is prioritizing measles vaccination for 39,212 medical personnel and 223,150 other healthcare workers across 14 regions with the highest measles burden, supported by real‑time logistics monitoring (SMILE) and recent BPOM approval of Bio Farma’s measles vaccine...
🔒 Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!
